Novartis AG
METHODS OF TREATMENT OF CANCER WITH REDUCED UBB EXPRESSION

Abstract:

The present invention provides compositions comprising a UBC antagonist and methods of use thereof for treating cancer in a patient. In some embodiments, the cancer patient may have a reduced expression level of a UBB gene product. Further provided are reagents and methods for detection of a UBB and/or UBC gene product.